NLRP3 and dengue disease: Moreover, NLRP3 inflammasome activation has also been evidenced in platelets from dengue-infected patients and from healthy controls exposed in vitro to the virus, which results from the increased ROS production by platelet mitochondria (via the RIP-1/RIP-3 kinase pathway) and leads to vascular leakage and monocyte activation [7,223].